UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 21, 2024

 

HORIZON SPACE ACQUISITION II CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

001-42406

 

N/A

(State or other jurisdiction

 

(Commission File Number)

 

(IRS Employer

of incorporation)

 

 

 

Identification Number)

 

1412 Broadway

21st Floor, Suite 21V

New York, NY 10018 

(Address of principal executive offices) 

 

Tel: (646)257-5537

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act.

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Units, consisting of one ordinary share, $0.0001 par value, and one Right to acquire one-tenth of one ordinary share

 

HSPTU

 

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

 

HSPT

 

The Nasdaq Stock Market LLC

Rights, each whole right to acquire one-tenth of one ordinary share

 

HSPTR

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 8.01 Other Events.

 

 As previously disclosed on a Current Report on Form 8-K filed on November 18, 2024, on November 18, 2024, Horizon Space Acquisition II Corp. (the “Company”) consummated the initial public offering (the “IPO”) of 6,000,000 units (the “Units”). Each Unit consists of one ordinary share, $0.0001 par value per share (each, a “Ordinary Share”), and one right (each, a “Right”), each one Right entitling the holder thereof to exchange for one-tenth of one Ordinary Share upon the completion of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000.

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 200,000 units (the “Private Units”) to the Company’s sponsor, Horizon Space Acquisition II Sponsor Corp. (the “Sponsor”). Each Private Unit consists of one Ordinary Share and one right. The Private Units were sold at a purchase price of $10.00 per Private Unit, generating gross proceeds to the Company of $2,000,000. In connection with the IPO, the Company issued 210,000 Ordinary Shares to Maxim Group LLC, the representative of the underwriters of the IPO (the “Representative”), as part of the underwriting compensation (the “Representative Shares”)

 

In connection with the IPO, the underwriters were granted an option to purchase up to 900,000 additional Units (the “Over-allotment Option”). On November 19, 2024, the Representative exercised the Over-allotment Option in full, and on November 21, 2024, the Representative consummated purchase of 900,000 Units (the “Option Units”), generating gross proceeds of $9,000,000. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of 13,500 Private Units (the “Additional Private Units”) to the Sponsor at a purchase price of $10.00 per Private Unit, generating gross proceeds of $135,000. The Company also issued additional 31,500 Representative Shares to the Representative.

 

In connection with the offering of the Option Units and the sale of Additional Private Units, the proceeds of $9,000,000 were placed in the trust account established for the benefit of the Company’s public shareholders and the underwriters of the IPO, with Wilmington Trust, N.A., as trustee.

 

The Company’s unaudited pro forma balance sheet as of November 21, 2024, reflecting the receipts of the proceeds of the offering of the Option Units and the sale of Additional Private Units on the same day, is included as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

 

Description of Exhibits

 

 

 

99.1

 

Unaudited Pro forma Balance Sheet as of November 21, 2024.

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Horizon Space Acquisition II Corp.

 

 

 

 

 

 

By:

/s/ Mingyu (Michael) Li

 

 

Name: 

Mingyu (Michael) Li

 

 

Title:

Chief Executive Officer

 

 

 

 

 

Date: November 25, 2024

 

 

 

 

 
3

 

EXHIBIT 99.1

 

HORIZON SPACE ACQUISITION II CORP.

PRO FORMA BALANCE SHEET

NOVEMBER 18, 2024

 

 

 

 

 

 

Pro Forma

 

 

 

Assets

 

November 18, 2024

 

 

Adjustments

 

 

As Adjusted

 

Current Assets

 

 

 

 

(Unaudited)

 

 

(Unaudited)

 

Cash `

 

$ 939,635

 

 

$ (135,000 )(b)

 

$ 804,635

 

Prepaid expense

 

 

2,000

 

 

 

-

 

 

 

2,000

 

Total Current Assets

 

 

941,635

 

 

 

(135,000 )

 

 

806,635

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash held in Trust Account

 

 

60,000,000

 

 

 

9,000,000  (a)

 

 

69,000,000

 

 

 

 

 

 

 

 

135,000  (b)

 

 

 

 

 

 

 

 

 

 

 

(135,000 )(c)

 

 

 

 

Total Assets

 

$ 60,941,635

 

 

$ 8,865,000

 

 

$ 69,806,635

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Ordinary Shares Subject to Possible Redemptions and Shareholders Equity

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Amount due to related party

 

$ 369,035

 

 

$ (135,000 )(b)

 

$ 234,035

 

Accrued expense

 

 

23,550

 

 

 

-

 

 

 

23,550

 

Over-allotment liability

 

 

89,730

 

 

 

(89,730 )(e)

 

 

-

 

Total Current Liabilities

 

 

482,315

 

 

 

(224,730 )

 

 

257,585

 

Total Liabilities

 

 

482,315

 

 

 

(224,730 )

 

 

257,585

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (Note 6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 6,000,000 shares subject to possible redemption

 

 

60,000,000

 

 

 

9,000,000  (d)

 

 

69,000,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholder's Equity :

 

 

 

 

 

 

 

 

 

 

 

 

Preferred share, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding

 

 

-

 

 

 

 

 

 

 

 

 

Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 2,135,000 shares and 2,180,000 issued and outstanding as actual and adjusted, respectively. (excluding 6,000,000 shares and 6,900,000 shares subject to possible redemption, as actual and adjusted, respectively)

(1)(2)

 

214

 

 

 

90  (a)

 

 

218

 

 

 

 

 

 

 

 

1  (b)

 

 

 

 

 

 

 

 

 

 

 

3  (c)

 

 

 

 

 

 

 

 

 

 

 

(90 )(d)

 

 

 

 

Additional paid-in capital

 

 

566,839

 

 

 

8,999,910  (a)

 

 

656,565

 

 

 

 

 

 

 

 

134,999  (b)

 

 

 

 

 

 

 

 

 

 

 

(135,003 )(c)

 

 

 

 

 

 

 

 

 

 

 

(8,999,910 )(d)

 

 

 

 

 

 

 

 

 

 

 

89,730  (e)

 

 

 

 

Accumulated deficit

 

 

(107,733 )

 

 

-

 

 

 

(107,733 )
Total Shareholder's Equity

 

 

459,320

 

 

 

89,730  (a)

 

 

549,050

 

Total Liabilities Ordinary Shares Subject to Possible Redemptions and Shareholder s Equity

 

$ 60,941,635

 

 

 

8,865,000  (b)

 

 

69,806,635

 

 

The accompany notes are an integral part of the pro forma financial statement.

 

 
1

 

 

HORIZON SPACE ACQUISITION II CORP.

 

NOTES TO PRO FROMA FINANCIAL STATEMENT

 

Note 1 — Closing of Over-allotment Options and Additional Private Units, and Issuance of Additional Representative Shares

 

The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of Horizon Space Acquisition II Corp. (the “Company”) as of November 18, 2024, adjusted for the closing of the underwriters’ over-allotment option and related transactions which occurred on November 21, 2024 as described below.

 

On November 18, 2024, the Company consummated its initial public offering (the “IPO”) of 6,000,000 units (“Units”). Each unit consists of one ordinary share, and one right to receive one-tenth (1/10) of one ordinary share. Each ten rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $60,000,000.

 

Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of 200,000 units (the “Private Placement Units”) to the Sponsor, at a price of $10.00 per Private Placement Unit, generating total proceeds of $2,000,000.

 

The Company also issued to the underwriter (“Representative”) 210,000 ordinary shares as part of the underwriting compensation (the “Representative Shares”) on the closing of the IPO.

 

On November 19, 2024, the underwriter notified the Company of its exercise of the over-allotment option in full to purchase additional 900,000 Units of the Company (the “Over-Allotment Option”). As a result, on November 21, 2024, 900,000 Units were sold to the underwriter at an offering price of $10.00 per Option Unit (the “Option Units” and together with the Units, collectively, the “Public Units”), generating gross proceeds of $9,000,000. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of additional 13,500 units (the “Additional Private Units” and together with the Initial Private Units, collectively, the “Private Units”) to the Sponsor at a purchase price of $10.00 per Additional Private Unit, generating gross proceeds of $135,000. In connection with the issuance and sales of the Option Units, the Company issued additional 31,500 Representative Shares to the underwriter.

 

 
2

 

 

Pro forma adjustments to reflect the sale of the Option Units, the sale of the Additional Private Units and the issuance of the additional Representative Shares described above are as follows:

 

Pro Forma Entries

Debit

Credit

(a)

Cash held in Trust Account

 $

   9,000,000

 

Ordinary shares

 $

90

 

Additional paid-in capital

 $

     8,999,910

 

To record the sale of 900,000 Option Units at $10.00 per Unit

(b)

Cash held in Trust Account

 $

      135,000

 

Amount due to related party

 

 

 $

135,000

 

 

 

Ordinary shares

 

 $

                  1

 

 

Cash

 

 

 

 

 $   

135,000

Additional paid-in capital

 $

        134,999

 

To record the sale of 13,500 Private Placement Units at $10.00 per Unit

 

(c)

Additional paid-in capital

 $

135,003

Ordinary shares

 $

                  3

Cash

 $

135,000

To record the issuance of the additional representative shares and payment of underwriters' fee arising from the sale of Option Units

(d)

Ordinary shares

 $

90

Additional paid-in capital

 $

   8,999,910

Ordinary shares subject to possible redemption

 $

     9,000,000

To accrete the carrying value of ordinary shares out of permanent equity into Ordinary shares subject to possible redemptions

(e)

Over-allotment liability

 $

      89,730

Additional paid-in capital

 $

        89,730

To transfer the over-allotment liability into additional paid-in capital upon exercise of the Option Units

 

 
3